Literature DB >> 21616559

Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients.

Khaled Ezzedine1, Yvon Gauthier, Christine Léauté-Labrèze, Sonia Marquez, Serge Bouchtnei, Thomas Jouary, Alain Taieb.   

Abstract

BACKGROUND: Mixed vitiligo (MV), the association of segmental vitiligo (SV) and nonsegmental vitiligo, has been rarely reported.
OBJECTIVE: The aim of this study was to delineate the clinical spectrum of MV through a case series of patients with typical SV associated with patchy bilateral vitiligo.
METHODS: This was a cross-sectional evaluation in the setting of a prospective observational study conducted in the vitiligo clinic of the department of dermatology in Bordeaux, France.
RESULTS: Nineteen patients with MV were identified. Four were male and 15 were female. Most patients had an onset of SV before the age of 18 years (18 of 19). In all patients, SV preceded nonsegmental vitiligo with a delay ranging from 6 months to more than 24 months. LIMITATIONS: This study was cross-sectional and based on a single-center experience.
CONCLUSION: MV is not yet part of a conventional classification. However, this entity may have been neglected until now and should be included in the classification of vitiligo in addition to SV and nonsegmental vitiligo. Moreover, MV may be essential to the understanding of the pathogenesis of vitiligo as a primary skin disorder.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21616559     DOI: 10.1016/j.jaad.2010.08.031

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

Review 1.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.

Authors:  K Ezzedine; H W Lim; T Suzuki; I Katayama; I Hamzavi; C C E Lan; B K Goh; T Anbar; C Silva de Castro; A Y Lee; D Parsad; N van Geel; I C Le Poole; N Oiso; L Benzekri; R Spritz; Y Gauthier; S K Hann; M Picardo; A Taieb
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

Review 3.  Vitiligo and Autoimmune Thyroid Disorders.

Authors:  Enke Baldini; Teresa Odorisio; Salvatore Sorrenti; Antonio Catania; Francesco Tartaglia; Giovanni Carbotta; Daniele Pironi; Roberta Rendina; Eleonora D'Armiento; Severino Persechino; Salvatore Ulisse
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-27       Impact factor: 5.555

Review 4.  The Role of TRM Cells in the Pathogenesis of Vitiligo-A Review of the Current State-Of-The-Art.

Authors:  Alicja Frączek; Agnieszka Owczarczyk-Saczonek; Waldemar Placek
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

5.  Profile of vitiligo in kumaun region of uttarakhand, India.

Authors:  Saurabh Agarwal; Amit Ojha; Shalini Gupta
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

6.  Role of histamine as a toxic mediator in the pathogenesis of vitiligo.

Authors:  Salil Kumar Panja; Biman Bhattacharya; Sitesh Chandra Lahiri
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

7.  Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism.

Authors:  Venkat Ratnam Attili; Sasi Kiran Attili
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

Review 8.  Autoimmunity in Segmental Vitiligo.

Authors:  Reinhart Speeckaert; Jo Lambert; Vedrana Bulat; Arno Belpaire; Marijn Speeckaert; Nanja van Geel
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.